Illumina | ILMN - Ebit


Illumina reported $260M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Agilent USD 444M 45M Jun/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Bio-Rad Laboratories USD 72.6M 750.1M Jun/2026
Boston Scientific USD 1.01B 232M Sep/2026
Bruker USD 69.6M 59.4M Jun/2026
Charles River Laboratories USD 119.89M 9K Jun/2026
Danaher USD 1.25B 118M Sep/2026
Dentsply International USD 84M 52M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Illumina USD 260M 21M Jun/2026
Intuitive Surgical USD 1.05B 69.9M Sep/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Laboratory Of America USD 418M 38.7M Sep/2026
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quest Diagnostics USD 479M 20M Sep/2026
Quidel USD -15.3M 12.1M Jun/2026
Repligen USD 24.31M 3.18M Sep/2026
Revvity USD 126.14M 43.36M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Standard Biotools USD -9.42M 12.51M Mar/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Waters USD 10M 138M Jun/2026